| No | 44 | 51.2% |
| NA | 6 | 7.0% |
| Induction chemotherapy |
|
|
| No | 65 | 75.6% |
| NA | 8 | 9.3% |
| TPF | 6 | 7.0% |
| TP | 3 | 3.5% |
| Cisplatin/5 Fluorouracil | 4 | 4.7% |
| Carboplatin/5 Fluorouracil | 0 | 0.0% |
| Concurrent chemotherapy |
|
|
| No | 47 | 54.7% |
| NA | 8 | 9.3% |
| Cisplatin | 15 | 17.4% |
| Carboplatin | 16 | 18.6% |
| Radiotherapy RT |
|
|
| No | 13 | 15.1% |
| NA | 8 | 9.3% |
| Alone (Adjuvant-definitive) | 34 | 39.5% |
| Concurrent (Adjuvant-definitive) | 31 | 36.0% |
| Acute RT toxicity |
|
|
| No | 17 | 19.8% |
| NA | 7 | 8.1% |
| Mucositis | 52 | 60.5% |
| Skin reaction | 10 | 11.6% |